Effect of Vitamin D Intake in Pregnancy to Prevent Recurrence of Gestational Diabetes
NCT ID: NCT03701087
Last Updated: 2018-10-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
EARLY_PHASE1
430 participants
INTERVENTIONAL
2018-08-02
2020-04-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Correlation Between Maternal Vitamin D Level And Preterm Birth
NCT03638037
The Relation Between Vitamin D and Gestational Diabetes Mellitus
NCT03665974
Correlation of Vitamin D Levels in Early Pregnancy With Gestational Diabetes and Pregnancy Outcomes
NCT05212519
Vitamin D Supplementation for the Prevention of GDM
NCT05208827
The Impact of Vitamin D Supplementation on Glucose Metabolism in Chinese Women With Former Gestational Diabetes Mellitus
NCT03138616
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
normal serum vitamin D
normal serum vitamin D
No interventions assigned to this group
low serum level of vitamin D
this arm will intake vitamin D 2800 IU daily
Vitamin D
2800 IU daily till 26 weeks of pregnancy
low serum vitamin D
this arm will intake placebo omega 3
Vitamin D
2800 IU daily till 26 weeks of pregnancy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vitamin D
2800 IU daily till 26 weeks of pregnancy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* pregnant patient with medical disorders
18 Years
38 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kasr El Aini Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
hadeer meshal
assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ashraf mohsen, lecturer
Role: PRINCIPAL_INVESTIGATOR
Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kasr El Ainy
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
assistant professor
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.